Featured Courses

Blazing Ahead With Advances in the Management of Adult Growth Hormone Disorder: A Podcast Series | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

Adult growth hormone deficiency (aGHD) is a debilitating, chronic disease. When left untreated, aGHD can lead to negative effects on body composition, muscle mass and strength, glucose and lipid profiles, bone metabolism, vitality, functional capacity, and quality of life.

Exploring the Evidence: Current Indications for the Use of CGM in Pediatric and Adult Patients | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Credit

Exploring the Evidence: Current Indications for the Use of CGM in Pediatric and Adult Patients

Glycemic Control and Beyond: Harnessing the Potential of SGLT-2 Inhibition Across Disease States | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

SGLT-2 inhibitors help patients with T2DM achieve glycemic control and promote weight loss, reductions in blood pressure, and significant benefits in heart failure and renal outcomes.

Brooke: A Teenage Patient With Daytime Hypoglycemia | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Credit

Case study on how to improve understanding of continuous glucose monitoring and optimize therapeutic management.

Emily: A Middle-aged Woman With T2D and Impaired Awareness of Hypoglycemia | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Credit

A patient case study to help lead clinicians to practice transformation and increased shared decision-making.

Challenges to Continuous Glucose Monitoring (CGM) Adoption and Use | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Credit

This educational activity explores the challenges to using and adopting continuous glucose monitoring.

CGM: Practical Approaches to Addressing Common Clinical Situations | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Credit

Continuous glucose monitoring: How clinicians can address common patient scenarios.

Up to the Challenge: Improving T2D Outcomes with GLP-1 RAs | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points

Reconsideration of the place of GLP 1 RAs in the treatment of diabetes is very recent, reflected in newest guidelines, and of significant educational importance for PCPs who may be unaware of this management approach for T2D. Adherence to therapy is a significant challenge clinicians face in the management of patients with T2D, necessitating an ongoing discussion of management strategies.

Update on Antiplatelet and Antithrombotic Therapy in the Cardiometabolic Patient | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CE for Pharmacists, CPEU Credit

This Clinical Brief is a short, to-the-point, online enduring activity covering key points, clinical pearls, and expert perspectives discussed throughout the CMHC West 2020 Live Online session.

The Now Generation and New Generation of GLP-1 RAs: Reshaping the Care of Patients with Type 2 Diabetes

AMA PRA Category 1 Credit(s)^TM

GLP-1 RAs are associated not only with substantial A1C reductions and enhanced glycemic control, but greater weight loss compared to many other agents among patients with T2DM.

Exploring CGM: Essentials for Primary Care | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Credit

As endocrine disorders are on the rise, it’s very important that primary care providers take a role in patient management. CGM has the opportunity to improve the lives of patients with endocrine disorders. Orienting PCPs with CGM devices via guided explanations from faculty and hands-on time with available devices will increase their knowledge of CGM as a tool, their confidence in discussing the CGM data with their patients, and competence in integrating CGM tools into their clinical practice.

Severe Hypoglycemia: The Frequently Forgotten Threat

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points

This program will discuss different aspects of diabetes technology from the scientific basis to the clinical integration of diabetes technology and time in range in their day to day practice.